Delivery Order SPE2DB25D3110-SPE2DB25FTCVS
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.87 firm fixed price delivery order contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical commodity, to support military healthcare programs. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This order is part of AmerisourceBergen's...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,387.45, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of November 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,485.96, is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,839.13, is a delivery order for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through February 10, 2025 and uses a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen has an Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,143.87, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 7, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,189.42 firm fixed-price delivery order is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,143.87, is a delivery order for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of March 17, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,688.07, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,958.34, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,164.32 firm fixed-price contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 2, 2025 and is not associated with a set-aside requirement. AmerisourceBergen holds a significant $999,999,999...